ClinicalTrials.Veeva

Menu

Immersive Virtual Reality Exergames and Office Workers' Cardiometabolic Health

G

Guangzhou University

Status

Not yet enrolling

Conditions

Metabolic Syndrome
Exergaming

Treatments

Behavioral: 12-week at-home immersive virtual reality exergame

Study type

Interventional

Funder types

Other

Identifiers

NCT06556784
VRGOWH2024Z

Details and patient eligibility

About

The worldwide increasing of prevalence of non-communicable diseases has grown the recognition of necessity for identifying the modifiable risk in preventing and managing these diseases. While, the office worker, as a representative group of physical inactivity, is exposed to risk factor of metabolic syndrome which is considered as the pathway of non-communicable diseases. This study mainly focuses on the purpose of examining the interventional efficacy of at-home immersive virtual reality exergame on several metabolic syndrome biomarkers among office workers. In addition, it purposes to determine the impacts of at-home immersive virtual reality exergame on lifestyle pattern of office workers. A 2-armed, single blinded randomized controlled trial (RCT) will be applied to examine the therapeutic effects of at-home immersive virtual reality exergame in this exploratory study. 120 Japanese office workers with less than 150 minutes per week of moderate to vigorous sports activities will be recruited by a convenience sample method. They are randomly allocated to two parallel groups, which including an intervention group: 12-week training of at least 150 minutes per week at-home immersive virtual reality exergame playing with a set device of Meta Quest 2, a control group: 12-week of maintaining regular exercise, eating, and working habits without making significant changes. During this 12-week trial, 3 main follow up steps are included at the timelines of 0 week, 6 weeks, 12 weeks. For each follow up, we will collect three types of variables, including major clinical risk factors of metabolic syndrome, lifestyle pattern factors of metabolic syndrome, and demographics (0 week only). To analysis the variance between intervention group and control group, mixed linear model will be applied to understand the efficacy result of this intervention. The variances of metabolic syndrome clinical risk factors between groups would be used to express the therapeutic effects of at-home immersive virtual reality exergame. The changes of lifestyle pattern factors would be applied to show the impacts of at-home immersive virtual reality exergame on lifestyle pattern.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 64 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18-64 years old
  • Capable of standing and exercising.
  • Having no history of diagnosis of heart disease, cancer, or dementia.
  • Being interested in playing with the exergames.
  • Willingness of adhering to a 12-week interventional exergame treatment.

Exclusion criteria

  • Individuals who are already engaged in more than 150 minutes per week of moderate to vigorous activities.
  • Individuals with some pharmacological treatments, some surgery (bariatric surgery), and some traditional Chinese medicine.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

120 participants in 2 patient groups

12-week at-home immersive virtual reality exergame
Experimental group
Description:
12-week training of at least 150 minutes per week at-home immersive virtual reality exergame playing with a set device of Meta Quest 2 and maintaining regular eating and working habits without making significant changes.
Treatment:
Behavioral: 12-week at-home immersive virtual reality exergame
12-week control in awaiting
No Intervention group
Description:
Maintaining regular eating and working habits without making significant changes throughout the 12 weeks.

Trial contacts and locations

0

Loading...

Central trial contact

Jiuling Li, Masters; Jing Zhao, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems